Cargando…
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression
microRNAs (miRNAs) are small non-coding RNAs acting as negative regulators of gene expression and involved in tumor progression. We recently showed that inhibition of the pro-metastatic miR-214 and simultaneous overexpression of its downstream player, the anti-metastatic miR-148b, strongly reduced m...
Autores principales: | Quirico, Lorena, Orso, Francesca, Esposito, Carla L., Bertone, Sofia, Coppo, Roberto, Conti, Laura, Catuogno, Silvia, Cavallo, Federica, de Franciscis, Vittorio, Taverna, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053324/ https://www.ncbi.nlm.nih.gov/pubmed/32174798 http://dx.doi.org/10.7150/ijbs.39768 |
Ejemplares similares
-
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
por: Catuogno, Silvia, et al.
Publicado: (2016) -
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells
por: Esposito, Carla Lucia, et al.
Publicado: (2014) -
Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
por: Catuogno, Silvia, et al.
Publicado: (2018) -
Coupling Aptamers to Short Interfering RNAs as Therapeutics
por: Cerchia, Laura, et al.
Publicado: (2011) -
Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
por: Esposito, Carla Lucia, et al.
Publicado: (2018)